Novartis has won a temporary reprieve from generic competition to its big-selling oral multiple sclerosis therapy Gilenya in the US, which accounts for around half its sales. The Swiss pharma group ...

Early evidence for a cough treatment digital therapeutic is compelling. A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour ...

Nearly every SaaS product is either integrating AI or planning to do so. However, the term “AI” has become so broad that it’s ...